Skip to main content
logo
Accelerate Diagnostics, Inc. (LON:0H8E)
London flag London · Delayed Price · Currency is GBP · Price in USD
0.0126
+0.0001 (0.80%)
At close: May 22, 2025

Accelerate Diagnostics Revenue

In the year 2024, Accelerate Diagnostics had annual revenue of $11.70M USD, down -2.99%. Accelerate Diagnostics had revenue of $2.82M in the quarter ending December 31, 2024, a decrease of -6.97%.

Revenue
$11.70M
Revenue Growth
-2.99%
P/S Ratio
0.01
Revenue / Employee
$109.33K
Employees
107
Market Cap
103.99K GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202411.70M-361.00K-2.99%
Dec 31, 202312.06M-693.00K-5.43%
Dec 31, 202212.75M970.00K8.23%
Dec 31, 202111.78M617.00K5.53%
Dec 31, 202011.17M1.87M20.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Oxford Nanopore Technologies 183.19M
Revenue Rankings

Accelerate Diagnostics News

More News